PLYX
Polaryx Therapeutics·NASDAQ
--
--(--)
--
--(--)
7.34 / 10
Outperform
Sentiment is Outperform (7.34/10) and fund‑flow score 7.75 (good), with small‑cap inflows positive despite overall negative trends. Analyst consensus is a unanimous Strong Buy, weighted rating 6.93. Capital inflows and bullish analyst views support a positive outlook.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
100%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Date2026-02-27
InstitutionMaxim Group
Times predicted1
Historical Win Rate100.0%
Is money flowing into or out of PLYX?
- PLYX holds a Bullish analyst rating, with 100% of experts assigning a Strong Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 7.34/10 (Outperform).
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
